News
News

The latest updates from AFAR.

Board Members in the News: S. Jay Olshansky and John W. Rowe co-author article in The Hill on the impact of low US birth rate on older Americans

May 25
2018

Board Members in the News: S. Jay Olshansky and John W. Rowe co-author article in The Hill on the impact of low US birth rate on older Americans

On May 21, 2018, The Hill published an article co-authored by AFAR board member, S. Jay Olshansky, Ph.D. and former board president John W. Rowe, M.D. “Effects of historically low birth rate will reverberate for years to come” focuses on the economic and social consequences of a historically low birth rate in the United States.  The authors consider how the future of Social Security and Medicare, which depends on the taxes on the workforce, will be threatened if there is less taxable income due to lower birth rates. Job re-training and offering flexible work arrangements for older…


View MoreREAD MORE


AFAR Experts in the News: Nir Barzilai, Leonard Guarente, James L. Kirkland, S. Jay Olshansky, Thomas T. Perls, and David A. Sinclair in The Boston Globe on innovative aging research

May 24
2018

AFAR Experts in the News: Nir Barzilai, Leonard Guarente, James L. Kirkland, S. Jay Olshansky, Thomas T. Perls, and David A. Sinclair in The Boston Globe on innovative aging research

On May 19, 2018, The Boston Globe spotlighted several AFAR experts in a feature exploring the range of research approaches to increasing longevity and healthspan. The article, “Scientists in Mass. and beyond are working to slow the aging process,” features: • AFAR Deputy Scientific Director, 1997 Beeson Scholar and 1994 AFAR Research Grant recipient, Nir Barzilai, M.D. • 2015 Irving S. Wright Award of Distinction winner Leonard Guarente, Ph.D. • 2012 Glenn/AFAR Breakthroughs in Gerontology Award recipient and President-elect James L. Kirkland, M.D., Ph.D. •  AFAR Board member S. Jay Olshansky, Ph.D. •  1998 Beeson Scholar Thomas…


View MoreREAD MORE


Board Member in the News: James L. Kirkland’s research on cellular senescence highlighted in Healio

May 23
2018

Board Member in the News: James L. Kirkland’s research on cellular senescence highlighted in Healio

On May 19, 2018, Healio highlighted the research of AFAR President-elect and 2012 Glenn/AFAR Breakthroughs in Gerontology Award recipient James L. Kirkland, M.D., Ph.D. “Metabolic bone disease researcher receives Frontiers in Science Award” focuses on Sundeep Khosla, M.D., who was awarded the Frontiers in Science Award by the American Association of Clinical Endocrinologists. Dr. Khosla acknowledges how “my collaborations with James L. Kirkland, M.D., Ph.D., an investigator in aging biology at Mayo, showing that cellular senescence played a key role in causing age-related bone loss in mice and likely also in humans” have…


View MoreREAD MORE


Grantee in the News: Louis Lapierre’s research on autophagy in Cell Reports, Futurity, and more.

May 22
2018

Grantee in the News: Louis Lapierre’s research on autophagy in Cell Reports, Futurity, and more.

On May 15, 2018, Cell Reports published research co-authored by 2015 AFAR Research Grant for Junior Faculty Louis Lapierre, Ph.D. In “Nuclear Export Inhibition Enhances HLH-30/TFEB Activity, Autophagy, and Lifespan,” the team found that “altering the nuclear export of HLH-30/TFEB can regulate autophagy and establishes the rationale of targeting XPO1 to stimulate autophagy in order to prevent neurodegeneration.” The research has been picked up by several publications, including by Futurity, where Dr. Lapierre states: “We and others think that by learning how to influence this process pharmacologically, we might be able to affect the progression…


View MoreREAD MORE


Grantee in the News: Domenico Praticò’s research on tau pathology and metabolic risk factor for neurodegenerative disease in Nature’s Molecular Psychiatry

May 22
2018

Grantee in the News: Domenico Praticò’s research on tau pathology and metabolic risk factor for neurodegenerative disease in Nature’s Molecular Psychiatry

On May 4, 2018, Nature’s Molecular Psychiatry published research co-authored by 1997 AFAR Research Grant and 1999 AFAR/Pfizer Innovations in Aging Research Award recipient Domenico Praticò, M.D. In “Elevated levels of brain homocysteine directly modulate the pathological phenotype of a mouse model of tauopathy,” Dr. Praticò and his peer authors found that “our findings support the novel concept that high Hcy level in the central nervous system is a metabolic risk factor for neurodegenerative diseases, specifically characterized by the progressive accumulation of tau pathology, namely tauopathies.” The research is available by subscription-only here, but…


View MoreREAD MORE




BACK TO TOPBACK TO TOP